QualityStocksNewsBreaks Archives - Page 516 of 1386

TuesdayOct 12, 2021 11:58 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Duncan Trussell to Keynote at Meet Delic: The World’s Premiere Psychedelic and Wellness Event

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today announced that Duncan Trussell will serve as a keynote speaker at Meet Delic on Nov. 6, 2021. An actor and stand-up comedian, Trussell co-created and appears in the Netflix animated series “The Midnight Gospel” and regularly travels the country performing comedy at festivals and shows. He also hosts the “Duncan Trussell Family Hour” podcast. Meet Delic is the largest and most comprehensive event to learn about the intersection of psychedelics, wellness and business with like-minded visionaries. Trussell's keynote will be a live taping of his podcast,…

TuesdayOct 12, 2021 11:27 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at KSCA Psychedelics Virtual Investor Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will present at the KCSA Psychedelics Virtual Investor Conference at 3:00 p.m. ET on Oct. 14, 2021. The event is slated to take place virtually on Oct. 13-14, 2021. Tryp’s Chief Financial Officer Luke Hayes will provide a live overview of the company's activities and elaborate on how Tryp is leading the next wave of psychedelic drug development beyond mental health with its focus on chronic pain and other indications. Interested parties should visit https://ibn.fm/1Y2RX to…

TuesdayOct 12, 2021 10:47 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Files International Patent Application in Continued Expansion of IP Portfolio

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, announced that it has filed an international patent application related to methods for the delivery of psychedelic medications by inhalation and devices for performing those methods. According to the update, the application, governed by the Patent Cooperation Treaty (“PCT”), brings the potential to obtain patent coverage in 153 countries. “The continued progression of our research programs guides our discovery of new molecules and differentiating treatment approaches,” said Doug Drysdale, the company’s CEO. “Continued innovation, as demonstrated by our expanding IP portfolio, positions Cybin as a leading…

TuesdayOct 12, 2021 10:46 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Receives Cannabis Cultivation License, Commences Grow Operations

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, announced that its subsidiary, Red White & Bloom Florida LLC, has received approval to begin growth operations at its 45,000-square-foot greenhouse in Apopka, Florida. The company has completed phase one of its cultivation strategy and is in the midst of a three-phase development plan for two Florida cultivation centers. The centers are part RWBYF’s plan to produce adequate inventory for existing and new dispensary openings planned for Q1 2022. The company had plants at the greenhouse ready to plant as soon as approval…

TuesdayOct 12, 2021 10:26 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) Announces Results of Annual General and Special Meeting

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) and/or its subsidiaries, a software-as-a-service (“SaaS”) technology company focused on delivering mobile live dealer technology to online gaming operators globally, today announced that each of the matters set forth in the company’s management information circular dated Sept. 10, 2021, were approved by the company’s shareholders at its annual general and special meeting. The matters put forth for approval by the shareholders at the meeting held on Oct. 8, 2021, included: (i) the election of Darcy Krogh, Guido Ganschow, James Penturn, Michele (Mike) Marrandino, William Scott and Jason Meretsky as directors of the company, (ii)…

TuesdayOct 12, 2021 9:55 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Launches Campaigns to Scale Fan Pass Platform, Attract Artists Across Multiple Genres

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced the official launch of its digital advertising and social media campaigns, aimed at attracting artists across various music genres. Entering the fourth quarter of 2021, the company’s Fan Pass platform has begun extending its brand awareness and artist offering to various artist groups and genre-specific targets that include industry managers, venues and music-related booking services. “As we enter the final quarter of the year, we have our sights set on testing, converting and growing our artist and fan bases. At the same time, we continue monetizing our service offering…

MondayOct 11, 2021 2:22 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices

RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate dosing protocols: routine administration, conservative administration and rapid administration, with each designed to ease a patient treating chronic pain into medical cannabis and treatment with THC if needed. Such dosing guidelines are just half of the equation. The other half is the delivery mechanism, as…

MondayOct 11, 2021 1:40 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Stands Distinct in World of Cancer Prevention, Treatment

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a proven early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. “AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical property and has achieved significant results,” reads a recent article. AnPac Bio has one of the largest sample libraries in the world, with more than 220,000 samples…

MondayOct 11, 2021 1:26 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Preparing for Clinical Trials Amid Growing Push for New Federally Approved Therapeutic

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) expects to soon launch a phase 2a clinical trial to determine the efficacy of its psychedelic drug candidate TRP-8802 in treating Prader-Willi Syndrome, hypothalamic obesity eating disorder resulting from removal of a brain tumor, and binge eating disorder. According to a recent article, TRP-8802 will be used in combination with psychotherapy under professional care to create the proper mindset for the neuroplasticity benefits of psilocybin to take full effect. Tryp then plans to proceed into phase 2b clinical trials with drug candidate TRP-8803 to test the trademarked product’s ability to penetrate the natural blood-brain…

MondayOct 11, 2021 1:08 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Poised Amid New Research Surrounding Psilocybin

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is likely to benefit from new research touting psilocybin mental health treatments. According to recent news from a group of Yale researchers, psilocybin has been found to counteract symptoms of depression (https://ibn.fm/NCORl). “Yale researchers found that a single dose of the naturally occurring psychedelic compound psilocybin can cause structural changes in the brain that counteract symptoms of depression,” reads a recent article quoting a Yale Daily News publication titled “Yale Researchers Discover Healing Effects of Psychedelic Drug.” In the piece published…

Site Search

Company Search

Category: QualityStocksNewsBreaks